Topics : Integrated health industry city site that will be a world model for self-sustained growth of human resources and technology (COI-NEXT)

The COI-NEXT (Co-Creation Opportunity Formation Support Program) Policy Focus Area (Full-Scale) Site Visit was held, where the PO, Deputy PO, AD, and MEXT staff gave advice and engaged in a lively exchange of opinions. Participating companies were also invited to attend.
Number of participants: 91 (on-site: 53, online: 38)

2024.05.17

The PI Training Program_Fist Progress Meeting was held for presentations and lively discussions.

2024.05.09

The third progress report meeting on the Support and Screening Committee for Startup Creation was held.

2024.04.25

The second progress report meeting on the Support and Screening Committee for Startup Creation was held.

2024.04.16

The first progress report meeting on the Support and Screening Committee for Startup Creation was held.

2024.04.19

A promotional video about support for the Creation and Growth of Startup has been released on the NCVC YouTube channel.
Click here for video >>

2024.04.10

The 12th Steering Committee meeting was held, and progress was shared with all members.

2024.03.22

A training session (WEB) for use of the Confocal Laser Scanning Microscope FV4000 was held. (On-site briefing held on 04.03 and 04.04.)

2024.02.14

Unit Meeting was held at the Support and Screening Committee for Startup Creation, where advice was given by members of the Startup Support Promotion Committee and a lively exchange of opinions took place.

2024.01.23

The PI Training Program_Kickoff Meeting was held for presentations and lively discussions.

2024.01.17

The 11th Steering Committee meeting was held and progress was shared with all members.

2023.12.22

The Support and Screening Committee for Startup Creation in FY2023 was held, and five new assignments were selected.

2023.11.15

Moonshot webinar "Recommendations for Light Sheet Microscopy" was held and attended by 54 people.

2023.10.27

JST 1st interim evaluation meeting was held.

2023.10.23

Pamphlet for Kento Imaging Support Center has been created.
PDF Download (Japanese only) >>

2023.10.11-13

Continuing from last year, we exhibited at Biojapan in collaboration with the Place for Co-Creation, National Circulation Center, Osaka Prefectural Government, and the Institute of Biomedical Innovation-Ken-Ei Kenkyuken.We exchanged information with visitors, focusing on the introduction of the newly launched "Organization for the Promotion of Health Metropolis Co-Creation" as well as the initiatives of the National Center for Medical Innovation.

2023.10.05

The second PI Training Program Review Committee meeting was held, and four new members were hired.

2023.09.04

A site visit to support the promotion of startup creation/growth under the Co-Creation Opportunity Formation Support Program (COI-NEXT) was held, where advice was given by members of the Startup Support Promotion Committee and a lively exchange of opinions took place.
Number of participants: 37 (on-site: 17, online: 20)

site visit

2023.08.30

The COI-NEXT (Co-Creation Opportunity Formation Support Program) Policy Focus Area (Full-Scale) Site Visit was held, where the PO, Deputy PO, AD, and MEXT staff gave advice and engaged in a lively exchange of opinions.
Participating companies were also invited to attend.
Number of participants: 82 (on-site: 57, online: 25)

site visit

2023.07.25

The 10th Steering Committee meeting was held and progress was shared with all members.

2023.06.28 - 30

Participated in the 75th Annual Meeting of the Japanese Society for Cell Biology to promote the KENTO Imaging Support Center.

2023.05.09

Moonshot Webinar "Introduction of Shared Equipment at Kento Imaging Support Center" was held and attended by 58 people.

2023.04.05

The 9th Steering Committee meeting was held and progress was shared with all members.

2023.03.09

The Raman microscopy seminar was held and attended by 72 people, including online participation.

【演者】
Katsushige Fujita (Osaka University, Graduate School of Engineering)
Takeshi Minamikawa (Post-LED Photonics Laboratory, The University of Tokushima)
Taisuki Koseki (Graduate School of Engineering, University of Tokyo)

2023.01.12

The 8th Steering Committee meeting was held and progress was shared with all members. In addition, the General Foundation for Research on Microbial Diseases of Osaka University, Osaka Public University, and Wellier Corporation were approved as new participating institutions.

2022.11.25

JST's FY2022 "Startup Creation/Growth Promotion Support" program has been adopted.
(Amount of support: up to 100 million yen, period: up to 3 years)

2022.09.07

The Kick-off Symposium for the Kento Imaging Support Center was held and attended by 102 people including from companies and universities

[ presenter ]
Keisuke Ota (Professor, Center for Advanced Imaging Research, Kurume University School of Medicine)
Yasushi Okada (Professor, Graduate School of Medicine, The University of Tokyo)
Li-Kun Phng (Team Leader, RIKEN Center for Frontier Biosciences)
Atsushi Miyawaki (Team Leader, RIKEN Neuroscience Research Center and Photonics Research Center)
Yu Ishii (Professor, Graduate School of Medicine, Osaka University)

2022.08.30

Official transition to full-scale support by JST has been approved.
(Amount of support: up to about 400 million yen/year, until FY2029)
We would like to thank all participating institutions for their cooperation and guidance over the past two years.
We look forward to your continued support.

2022.08.10

The registration site for the Kick-off Symposium of Kento Imaging Support Center on September 7 has been released.

2022.07.06

The 6th Steering Committee meeting was held to report progress to all members.

2022.06.24

The site visit was conducted as a transitional evaluation (second- phase evaluation) to full-scale support by JST.

2022.05.18

Kowa Corporation, a participating organization in the Health and Medical Data Platform, has pre-released a health promotion support [Suita Self-Care Suite Trial].

2022.04.22

Biocommunity Kansai (BiocK) has been recognized as a "Global Biocommunity" by the Cabinet Office. The National Cardiovascular Center will continue to contribute to BiocK as a key institution of the Digital Biohealth Subcommittee.

2022.04.22

NexGen Corporation issued a press release on the occasion of its participation in the "Place for Co-Creation.

2022.04.06

The 5th Steering Committee was held to share the progress with all members. The SC approved MUFG Bank, Hankyu Hanshin Holdings Co., Ltd., JCR Pharma Co., Ltd., and NEXGEN Co., Ltd. as new participating institutions.

2022.02.25

JST allowed us temporary promotion to full-scale support. The second phase evaluation is to be implemented at the end of April this year.

2022.01.13

JST conducted the first phase evaluation for the promotion to full-scale support.

2021.12.15

Shigehiro Asano, the subーproject leader of COI-NEXT, delivered a lecture whose title was “From Keihanshin area to all over Japan. －our project to create an innovation through KENTO－” at HVC KYOTO post-event 2, “To develop innovation ecosystem － What is it that we need in Kansai district?”. This event was organized by JETRO and Kyoto Research Park Corp.

2021.12.02

Naoki Mochizuki, the project leader of COI-NEXT, delivered a lecture, “The project of digital transformation for Biohealth at COI-NEXT”, at the 2nd industry-academia-government collaboration seminar hosted by Osaka prefecture and PMK initiative.

2021.11.30

The representatives from the Kansai Bureau of Economy, Trade, and Industry visited COI-NEXT and had a discussion on promoting collaboration with business.

2021.11.26

A delegation from MEXT visited COI-NEXT. They took a tour of the COI-NEXT site and had an active exchange of opinions on the project.

2021.11.25

A skull session with bureaucrats from MEXT and JST was held on the web. There was an active discussion on COI-NEXT.

2021.10.06

The 3rd steering committee meeting was held. The participants reviewed the progress of the project. They also welcomed AIR WATER INC., Kowa Company, Ltd., and JSPA(Japan Selfcare Promotion Association) as new participating institutions.

2021.07.14

A site visit was conducted by JST at COI-NEXT, and opinions were exchanged about the place for co-creation.

2021.07.07

The second Steering Committee meeting was held to report the progress with all members.
At this meeting, Kobe University was approved as a new participating institution. In addition, the University of Hyogo, Tohoku University, Kumamoto University, and the University of Tokushima joined the project as a member of the Data Utilization Promotion Fund (for two years).

2021.07.01

Information on shared imaging equipment is posted on the website.

2021.06.24

The Program Officer and Sub Program Officer of JST for COI-NEXT visited our center and exchanged opinions.

2021.04.07

The first Steering Committee meeting was held to share the progress with all members.
LSI Medience Corporation and Mizuho Bank, Ltd. were also approved as new participating institutions.

2021.04.01

The terms of participation for "COI-NEXT" have been established.

2021.01.29

A kick-off meeting was held for all members of "COI-NEXT".

2021.01.28

The site was opened.

2020.12.15

"COI-NEXT (bio-field / full-fledged type)" was adopted.

Report on the 3rd Startup Seminar

The 3rd Startup Seminar was held on Tuesday, November 5th.
This time, we held a VC capitalist roundtable discussion, with Mikio Kawahara of Utokyo Innovation Platform Co., Ltd., Hiroyuki Hasegawa of Mitsubishi UFJ Capital Co., Ltd., and Hajime Oshita of Medventure partners,Inc.. They discussed what kind of healthcare startups VCs are looking for and what points to consider when evaluating them.

We would like to express our sincere gratitude to everyone who participated. Please join us for future startup seminars!

◆ JST COI-NEXT Program × Life Science Incubation Council
VC capitalist roundtable
· Date snd time : November 5^th (Tue), 2024 18:00-19:30 JST
· The venue : LINK-J WEST

· Speakers :: Utokyo Innovation Platform Co., Ltd. Mikio Kawahara
Mitsubishi UFJ Capital Co.,Ltd. Hiroyuki Hasegawa
Medventure partners, Inc. Hajime Oshita

Upcoming Startup Seminars

Panel Discussion Report [ BioJapan2024 ]

On Friday, October 11^th, we co-hosted a panel discussion with the Life Science Incubation Council at BioJapan, featuring life science industry associations from Japan, the US, the UK, and Canada.
This time, we invited representatives from Newsight Tech Angels (Japan), Life Science Nation (US), MedCity (UK), and BioQuebec (Canada), which have long supported the globalization of startups around the world, to discuss how startups should utilize industry associations and partners in each country to advance globalization.

Thank you to everyone who attended.

◆ JST COI-NEXT Program × Life Science Incubation Council
BioJapan 2024 Panel Discussion inviting the life science sector organizations from Japan, US, UK and Canada
· Timing of the seminar : October 11^th (Fri), 2024 15:35-16-35 JST
· Place of the seminar : BioJapan2024 Event Hall Presentation Stage D

· Speakers :: Mr Nao Yoshizawa, Founder, Life Science Incubation Council
Dr Tsuneaki Sakata, Chairman, NPO kinki Bio-Industry Development Organization
Mr Shigehiro Asano, Director, NCVC
Mme Helene Moore, BioQuebec
Ms Claire Jeong, Vice President, Life Science Nations
Ms Angela Kukula, CEO, MedCity

BioJapan Exhibition Report

We exhibited at a booth at BioJapan, which was held at PACIFICO YOKOHAMA from October 9^th to 11^th.
Osaka Prefecture, NCVC, and COI-NEXT（NCVC） exhibited jointly. As COI-NEXT（NCVC）, we introduced the Kento Imaging Support Center and startup support issues.

Thank you to everyone who visited our booth during the event.

◆ BioJapan
· Date and Time : October 9^th (Wed) - October 11^th (Sun) 10:00 - 17:00
· The venue : PACIFICO YOKOHAMA (A-42)
· Contents : Panel exhibits (introductions to the COI-NEXT (NCVC), the Kento Imaging Support Center, startup support issues, etc.)

Report on exhibiting at the 83^rd Annual Meeting of the Japanese Cancer Association

We exhibited at the 83^rd Annual Meeting of the Japanese Cancer Association, held from September 19^th to 21^st, and promoted the Kento Imaging Support Center.

Thank you to everyone who visited our booth during the event.

◆ the 83^rd Annual Meeting of the Japanese Cancer Association
· Date and Time : September 19^th (Thu) – September 21^st (Sun)
· The venue : Fukuoka International Congress Center, Marine Messe Fukuoka Hall B
· Contents : Panel exhibits (the Kento Imaging Support Center)

Report on the 3rd Progress Report Meeting of the PI Development Program

On Friday, October 4th, the third progress report meeting of the PI Development Program was held.
Three of the nine researchers selected for the PI Development Program gave presentations on the progress of their research, and there was lively discussion between the organizers and other recipients.

The next general meeting, including the recipients and organizers of the PI Development Program, is scheduled to be held on-site (January 2025).

Report on participating in the " Pre-EXPO Medical care in the Future "

On Friday, September 27th, we participated in the “Future Medical Pre-EXPO” held at Nakanoshima Qross. This international event aims to promote the potential and efforts of life sciences in Osaka and Kansai to the Kansai Consul General and industry, as well as to deepen exchanges between overseas stakeholders and companies.
At this event, PL Mochizuki gave a presentation as the leader of the Biocommunity Kansai (BiocK) Subcommittee on Digital Biohealth. We also exhibited posters promoting the COI-NEXT program (NCVC).

L) PL Mochizuki's presentation R) Posters

L) Poster exhibition venue R) Official mascot of the Osaka-Kansai Expo (MYAKU-MYAKU)

Startup Seminar [Special Edition] Report

On Wednesday, September 18th, we held a "Startup Seminar [Special Edition]".
This time, we invited speakers representing Mayo Clinic, the world's largest non-profit, comprehensive medical group in the United States, to speak about collaboration between the hospital and Japanese companies, and support for Japanese startups expanding into the US.In addition to clinical work, Mayo Clinic is engaged in a variety of research programs, translational research, and building an ecosystem for medical startups.

This time, more than 50 people participated, even though the event was held early in the morning.
We look forward to seeing you at the next Startup Seminar.

COI-NEXT (NCVC) x LSIC 2024 Results Reporting Session

On Thursday, September 5th, the “2024 Results Reporting Session” was held at the National Cerebral and Cardiovascular Center as part of our support for startup creation.
This time, the session was co-hosted with the Life Science Incubation Council (LSIC) and was held in a hybrid format, both on-site and online. The content of the session provided a deeper understanding of the importance of overseas ecosystems and collaborative networks, and lively exchanges of opinions took place in a very successful environment.

We will continue to work with LSIC to provide support with an awareness of collaboration with overseas companies.

FY2024 Startup Creation Support Site Visit and Event Report

On Thursday, September 5th, a site visit for the "2024 Startup Creation/Growth Promotion Support" was held at the National Cerebral and Cardiovascular Center.
This time, the event was held in a hybrid format, combining on-site and online sessions, and representatives from the JST and MEXT participated, resulting in a lively exchange of opinions.

After the site visit, as part of the startup support efforts, Toru Seo (Newsight Tech Angels Inc.) was invited to hold a mentoring event for those selected for the support project. Specific discussions were held on commercialization, including how to capture the market, marking an important step towards future business development.

Based on the advice we received, we will continue to work hard towards further development of our base.

The site visit venue

Mentoring event venue

Report on the 1st Startup Seminar

The “1st Startup Seminar” was held on Wednesday, August 28th.
This time, we had Mr. Nao Yoshizawa give a lecture titled “ Shikujiri Sensei.‘’ He taught me the basics of learning from past mistakes and building a strong business strategy without repeating the same mistakes.
Although the event was held only online due to the typhoon, more than 50 people participated.
The Startup Seminar will be held in a series of 5 sessions, so please join us next time.

Nao Yoshizawa

Speaker：
Bio-expert at the Cabinet Office, Lawyer, Patent Attorney, and Information Processing Engineer
Nao Yoshizawa

2024.11.11: The following press release was issued by project leader Mochizuki Naoki and Yamagata University School of Medicine.
Zonated Wnt/β-catenin signal-activated cardiomyocytes at the atrioventricular canal promote coronary vessel formation in zebrafish
2024.09.19: There was a press release on the study of Dr. Takahisa Furukawa, the leader of R&D theme 5.
Ccrk-Mak/Ick signaling is a ciliary transport regulator essential for retinal photoreceptor survival
2024.09.17: Nobuhiro Nakai (Kobe University), a recipient of the PI Development Program, has been selected for the FY2024 “Advanced Research ＆ Development Programs for Medical (AMED-PRIME)”. (in Japanese only.)
2024.08.28: There was a press release on the study of Dr. Hiroshi Seno, the leader of R&D theme 2.
Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning
2024.06.25: Atsushi Mitsuhashi (Tokushima University), a recipient of the PI Development Program, has been selected for the FY2023 “ Fusion oriented Research for disruptive Science and Technology (JST). (in Japanese only.)
2022.10.25: There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
A high WBC count can predict atrial fibrillation: The Suita Study.
2022.08.24: There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Serum uric acid levels associated with risk of diabetes mellitus in peri- and postmenopausal women living in urban areas.
2022.08.17: There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Association of liver enzymes and alcohol intake with risk of developing diabetes mellitus among urban area residents.
2022.07.25: Research and Development Project 6 Leader Yoshihiro Kokubo, Specially Appointed Director, has published on the Health Checkup Department WEB site.
Evidence from Japan of 10 items of lifelong health support to be used in the new health guidance of the Heart Failure Severe Prevention Project
2022.03.04: There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Stair climbing and incident atrial fibrillation: a prospective cohort study
2022.01.26: There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Mild Hypertensive Retinopathy and Risk of Cardiovascular Disease: The Suita Study
2021.12.08: There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Developing a Stroke Risk Prediction Model Using Cardiovascular Risk Factors: The Suita Study --Stroke Risk in Urban Population. Cerebrovascular Diseases. 2021.

When research related to this program or research using the equipment installed in the "Kento Imaging Support Center" is published in a paper, it will be introduced on the website of the Place for Co-Creation and reported to JST as an achievement.

[ Research related to this program ]
Please indicate your grant number below.
Grant number of the Co-Creation Field: JPMJPF2018
When your paper is accepted, please inform the Co-Creation Field Support Office.
We will publish your paper as a result on the website of Place for Co-Creation.

( For inquiries, please contact )
National Cerebral and Cardiovascular Center
Open Innovation Center, Industry-Academia Collaboration Division
6-1 Kishibe Shinmachi, Suita City, Osaka, Japan
E-mail: coi-next-so@ml.ncvc.go.jp
TEL: 06-6170-1070

Topics